A team of EMBL scientists and colleagues have analysed how the novel coronavirus affects proteins in human cells. They identified several human…
Researchers at EMBL Heidelberg have identified sequences in human proteins that might be used by SARS-CoV-2 to infect cells. They have discovered…
Open letter galvanises life science community in support of open COVID-19…
A new lineage of coronavirus was first identified in the UK, but why is it spreading much more rapidly within the…
A note on the coronavirus variant B.1.1.7, which has first been described in the U.K. and has spread to 57 countries. The note summarises…
It’s almost a year since the coronavirus outbreak was declared a pandemic, affecting all our lives. While the virus continues its grip on the…
Biotechnology company BioNTech and Johannes Gutenberg University Mainz conduct collaborative research with EMBL scientists at the beamline P12 in…
Researchers have studied SARS-CoV-2 replication in cells and obtained detailed insights into the alterations induced in infected cells. This…
By screening hundreds of sybodies (synthetic mini-antibodies), scientists have identified one that might stop SARS-CoV-2 from infecting human cells.…
Open access data benefits millions of scientists around the world and is essential for a rapid response to the COVID-19…
Scientists from the Beltrao Group at EMBL-EBI and collaborators identified drug targets common to SARS-CoV-2, SARS-CoV-1, and MERS-CoV, three…
European collaboration receives funding to explore risks and impact of future infectious disease…
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive